Valsartan (Diovan)

Trade Name : Diovan

Novartis Pharmaceuticals Corporation

TABLET

Strength 80 mg/1

VALSARTAN Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Valsartan (Diovan) which is also known as Diovan and Manufactured by Novartis Pharmaceuticals Corporation. It is available in strength of 80 mg/1 per ml. Read more

Valsartan (Diovan) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • WARNING: FETAL TOXICITY
  • See full prescribing information for complete boxed warning.
  • When pregnancy is detected, discontinue Diovan as soon as possible. ()
  • Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. ()
  • Diovan is anu00a0angiotensin II receptor blocker (ARB) indicated for:
  • Treatment of hypertension
  • Treatment of heart failure
  • Post-myocardial infarction;
  • No data
  • 40 mg are scored yellow ovaloid tablets with beveled edges, imprinted NVR/DO (Side 1/Side 2)
  • 80 mg are pale red almond-shaped tablets with beveled edges, imprinted NVR/DV
  • 160 mg are grey-orange almond-shaped tablets with beveled edges, imprinted NVR/DX
  • 320 mg are dark grey-violet almond-shaped tablets with beveled edges, imprinted NVR/DXL
  • Tablets (mg): 40 (scored), 80, 160, 320
  • ntttttttDo not use in patients with known hypersensitivity to any component.ntttttt
  • ntttttttDo not coadminister aliskiren with Diovan in patients with diabetes .ntttttt
  • Known hypersensitivity to any component.
  • Do not coadminister aliskiren with Diovan in patients with diabetes ()
  • No data
  • Observe for signs and symptoms of hypotension ()n
  • Monitor renal function and potassium in susceptible patients (, )
  • Hypertension:
  • Heart Failure:
  • Post-Myocardial Infarction:
  • No data
  • Potassium-sparing diuretics, potassium supplements or salt substitutes may lead to increases in serum potassium, and in heart failure patients, increases in serum creatinine ()n
  • Non-Steroidal Anti-Inflammatory Drug (NSAID) use may lead to increased risk of renal impairment and loss of antihypertensive effect ()
  • Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia ()
  • Lithium: Increases in serum lithium level and lithium toxicity ()
  • Lactation:
  • Pediatrics:
  • Limited data are available related to overdosage in humans. The most likely manifestations of overdosage would be hypotension and tachycardia; bradycardia could occur from parasympathetic (vagal) stimulation. Depressed level of consciousness, circulatory collapse and shock have been reported. If symptomatic hypotension should occur, institute supportive treatment.
  • Diovan (valsartan) is not removed from the plasma by hemodialysis.
  • Valsartan was without grossly observable adverse effects at single oral doses up to 2000 mg/kg in rats and up to 1000 mg/kg in marmosets, except for salivation and diarrhea in the rat and vomiting in the marmoset at the highest dose (60 and 31 times, respectively, the MRHD dose on a mg/m basis) (Calculations assume an oral dose of 320 mg/day and a 60-kg patient).
  • Diovan (valsartan) is a nonpeptide, orally active, and specific angiotensin II receptor blocker acting on the AT receptor subtype.
  • Valsartan is chemically described as -(1-oxopentyl)--[[2u2032-(1-tetrazol-5-yl) [1,1u2032-biphenyl]-4-yl]methyl]-L-valine. Its empirical formula is CHNO, its molecular weight is 435.5, and its structural formula is:
  • ttu00a0u00a0u00a0u00a0u00a0ntttttttn
  • Valsartan is a white to practically white fine powder. It is soluble in ethanol and methanol and slightly soluble in water.
  • Diovan is available as tablets for oral administration, containing 40 mg, 80 mg, 160u00a0mg or 320 mg of valsartan. The inactive ingredients of the tablets are colloidal silicon dioxide, crospovidone, hydroxypropyl methylcellulose, iron oxides (yellow, black and/or red), magnesium stearate, microcrystalline cellulose, polyethylene glycol 8000, and titanium dioxide.
  • No data
  • No data
  • No data
  • Diovan (valsartan) is available as tablets containing valsartan 40 mg, 80 mg, 160 mg, or 320 mg. All strengths are packaged in bottles as described below.
  • The 40 mg tablets are scored on one side and ovaloid with bevelled edges. 80 mg, 160 mg, and 320 mg tablets are unscored and almond-shaped with bevelled-edges.
  • Store at 25u00b0C (77u00b0F); excursions permitted to 15u00b0C-30u00b0C (59u00b0F-86u00b0F)u00a0[see USP Controlled Room Temperature].
  • Protect from moisture.
  • Dispense in tight container (USP).
  • Advise the patient to read the FDA-approved patient labeling (Patient Information).
  • Pregnancy:n- [see Warnings and Precautions (5.1), Use in Specific Populations (8.1)]
  • Lactation:n- [see Use in Specific Populations (8.2)]
  • Symptomatic Hypotension:n- [see Warnings and Precautions (5.2)]
  • Hyperkalemia:n- [see Drug Interactions (7.1)]
  • T2019-66
  • PATIENT INFORMATION
  • DIOVAN (DYEu2019-o-van)
  • (valsartan) Tablets
  • Read the Patient Information that comes with DIOVAN before you take it and each time you get a refill. There may be new information. This leaflet does not take the place of talking with your doctor about your medical condition or treatment. If you have any questions about DIOVAN, ask your doctor or pharmacist.
  • What is the most important information I should know about DIOVAN?
  • DIOVAN can cause harm or death to an unborn baby. Talk to your doctor about other ways to lower your blood pressure if you plan to become pregnant. If you get pregnant while taking DIOVAN, tell your doctor right away.
  • What is DIOVAN?
  • DIOVAN is a prescription medicine called an angiotensin receptor blocker (ARB). It is used in adults to:
  • DIOVAN is not for children under 6 years of age or children with certain kidney problems.
  • High Blood Pressure (Hypertension).
  • High blood pressure makes the heart work harder to pump blood throughout the body and causes damage to the blood vessels. If high blood pressure is not treated, it can lead to stroke, heart attack, heart failure, kidney failure and vision problems.
  • Heart Failure
  • Heart Attack (Myocardial Infarction):
  • What should I tell my doctor before taking DIOVAN?
  • Tell your doctor about all your medical conditions including whether you:
  • Tell your doctor about all the medicines you take
  • Know the medicines you take. Keep a list of your medicines with you to show to your doctor and pharmacist when a new medicine is prescribed. Talk to your doctor or pharmacist before you start taking any new medicine. Your doctor or pharmacist will know what medicines are safe to take together.
  • How should I take DIOVAN?
  • What are the possible side effects of DIOVAN?
  • DIOVAN may cause the following serious side effects:
  • Injury or death to an unborn baby.n- u201cWhat is the most important information I should know about DIOVAN?u201d
  • Low Blood Pressure (Hypotension).
  • Kidney problems.
  • The most common side effects of DIOVAN used to treat people with high blood pressure include:
  • Side effects were generally mild and brief. They generally have not caused patients to stop taking DIOVAN.
  • The most common side effects of DIOVAN used to treat people with heart failure include:
  • Common side effects of DIOVAN used to treat people after a heart attack which caused them to stop taking the drug include:
  • Tell your doctor if you get any side effect that bothers you or that does not go away.
  • These are not all the possible side effects of DIOVAN. For a complete list, ask your doctor or pharmacist.
  • How do I store DIOVAN?
  • General information about DIOVAN
  • Medicines are sometimes prescribed for conditions that are not mentioned in patient information leaflets. Do not use DIOVAN for a condition for which it was not prescribed. Do not give DIOVAN to other people, even if they have the same symptoms you have. It may harm them.
  • This leaflet summarizes the most important information about DIOVAN. If you would like more information, talk with your doctor. You can ask your doctor or pharmacist for information about DIOVAN that is written for health professionals.
  • For more information about DIOVAN, ask your pharmacist or doctor, visit on the Internet, or call .
  • What are the ingredients in DIOVAN?
  • Active ingredient: u00a0valsartan
  • Inactive ingredients: colloidal silicon dioxide, crospovidone, hydroxypropyl methylcellulose, iron oxides (yellow, black and/or red), magnesium stearate, microcrystalline cellulose, polyethylene glycol 8000, and titanium dioxide
  • Distributed by:
  • Novartis Pharmaceuticals Corporation
  • East Hanover, NJ 07936
  • u00a9 Novartis
  • T2019-67Revised: 06/2019
  • PRINCIPAL DISPLAY PANEL
  • Package Label u2013 n- 40 mg
  • Rx Onlyntttttttu00a0u00a0u00a0u00a0u00a0nntttttttu00a0u00a0u00a0u00a0u00a0ntttttttNDC 0078-0423-15
  • Diovanu00ae
  • valsartan
  • 40 mg
  • 30 Scored Tablets
  • NOVARTIS
  • PRINCIPAL DISPLAY PANEL
  • Package Label u2013 n- 80 mg
  • Rx Onlyntttttttu00a0u00a0u00a0u00a0u00a0nntttttttu00a0u00a0u00a0u00a0u00a0ntttttttNDC 0078-0358-34
  • Diovanu00ae
  • valsartan
  • 80 mg
  • 90 Tablets
  • NOVARTIS
  • PRINCIPAL DISPLAY PANEL
  • Package Label u2013 n- 160 mg
  • Rx Onlyntttttttu00a0u00a0u00a0u00a0u00a0nntttttttu00a0u00a0u00a0u00a0u00a0ntttttttNDC 0078-0359-34
  • Diovanu00ae
  • valsartan
  • 160 mg
  • 90 Tablets
  • NOVARTIS
  • PRINCIPAL DISPLAY PANEL
  • Package Label u2013 n- 32n- 0 mg
  • Rx Onlyntttttttu00a0u00a0u00a0u00a0u00a0nntttttttu00a0u00a0u00a0u00a0u00a0ntttttttNDC 0078-0360-34
  • Diovanu00ae
  • valsartan
  • 320 mg
  • 90 Tablets
  • NOVARTIS

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Dossiers and Stability Studies

Dossiers and Stability Studies

STABILITY STUDIES STABILITY, BA / BE STUDIES Due to our active

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71247 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2024 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.